TITAN OF INDUSTRY

Moderna CEO, Stéphane Bancel discusses the challenges and opportunities in the biopharma industry, emphasizing the high failure rate of drugs in clinical trials, with 90% not getting approved. Bancel highlights the potential of AI to revolutionize drug discovery and development, particularly in creating new molecules and accelerating clinical processes. In continuation, he exemplifies the innovative use of mRNA technology, which has shown promise in personalized medicine and cancer treatment. Bancel also comments on the importance of integrating AI into healthcare to enhance efficiency and democratize access to medical advancements and improve interactions with regulators with access to newly accessible data.